The SUMO1 modification of PTEN at Lys266 in its C2 domain was shown to increase the localization of PTEN at the plasma membrane, resulting in the suppression of the PI3K-AKT pathway signaling and inhibition of anchorage-independent cell growth and tumor growth in vivo [147]. This evidence concerns the gene PIK3CD and neoplasm.